Search filters

List of works by Bernard Escudier

A 10-year clinical experience with intermittent hormonal therapy for prostate cancer

scientific article published in March 2003

A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies

scientific article published on 12 May 2015

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

scientific article

A germline mutation in PBRM1 predisposes to renal cell carcinoma

scientific article

A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients

scientific article

A phase I pharmacokinetic and biological correlative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma

scientific article

A phase II study of irinotecan in patients with advanced renal cell carcinoma

scientific article published on July 2003

A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases

scientific article published on 28 September 2013

A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer

scientific article

Accelerated MVAC chemotherapy in patients with advanced bladder cancer previously treated with a platinum-gemcitabine regimen.

scientific article published on 22 February 2012

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

scientific article

Advanced renal cell carcinoma: current and emerging management strategies

scientific article published on January 2007

Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes

scientific article published on 3 August 2015

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

scientific article

Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients

scientific article published in April 2004

Antiangiogenic therapy combined with immune checkpoint blockade in renal cancer

scientific article published on 11 April 2017

Are tyrosine kinase inhibitors still active in patients with metastatic renal cell carcinoma previously treated with a tyrosine kinase inhibitor and everolimus? Experience of 36 patients treated in France in the RECORD-1 Trial

scientific article published on 17 January 2013

Assessment of Early Tumour Shrinkage: Ready for Integration in the Treatment Strategy for Metastatic Renal Cell Carcinoma?

scientific article published on 5 August 2016

Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study

scientific article published on 19 January 2010

Axitinib for the Management of Metastatic Renal Cell Carcinoma ⬇️

scientific article published on January 1, 2011

Axitinib in metastatic renal cell carcinoma

scientific article published on May 2015

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

scientific article

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

scientific article

Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma

scientific article published on October 2008

Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

scientific article published on 22 July 2010

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

scientific article

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

scientific article published on 29 August 2017

Cabozantinib for the treatment of renal cell carcinoma

scientific article published on 11 November 2016

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

scientific article

Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.

scientific article published on 8 January 2018

Chemo-immunotherapy in RCC: the end of a story

scientific article published in February 2010

Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients

scientific article published in April 2008

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

scientific article

Clinical implications of body composition assessment by computed tomography in metastatic renal cell carcinoma

scientific article published on 09 January 2014

Combination Interleukin-2 and Doxorubicin in Advanced Adult Solid Tumors: Circumvention of Doxorubicin Resistance in Soft-Tissue Sarcoma?

scientific article published in May 1999

Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: a critical review

scientific article published on 05 July 2011

Complete remission with tyrosine kinase inhibitors in renal cell carcinoma.

scientific article

Considerations for the design of future clinical trials in metastatic renal cell carcinoma

scientific article

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

scientific article published on 14 November 2017

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

scientific article published on 01 August 2020

Current and future strategies in nonclear-cell metastatic renal cell carcinoma

scientific article published on September 2015

Cutaneous side-effects of kinase inhibitors and blocking antibodies

scientific article

Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be Answered

scientific article published in November 2016

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha

scientific article

Dermatologic symptoms associated with the multikinase inhibitor sorafenib

scientific article

Development and validation of a real-time PCR assay for the detection and quantitation of p53 recombinant adenovirus in clinical samples from patients treated with Ad5CMV-p53 (INGN 201) ⬇️

scientific article published on December 1, 2003

Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials

scientific article

Does a reasonable treatment approach beyond second-line exist?

scientific article published on September 2013

Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors

scientific article published on 4 January 2018

Early PSA response is an independent prognostic factor in patients with metastatic castration-resistant prostate cancer treated with next-generation androgen pathway inhibitors

scientific article published on 2 May 2016

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

scientific article published on January 2008

Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma.

scientific article

Emerging efficacy endpoints for targeted therapies in advanced renal cell carcinoma

scientific article published on May 2006

Emerging tyrosine kinase inhibitors for the treatment of renal cancer

scientific article published on 18 May 2015

Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction

scientific article (publication date: 15 October 2002)

Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71].

scientific article published on 3 January 2018

Erratum: Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

scientific article published in Nature

Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy

scientific article published on 12 August 2017

Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma

scientific article published on 6 November 2014

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

scientific article published on February 2004

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

scientific article published on February 2004

Experience with sorafenib and the elderly patient

scientific article published on 31 December 2009

Feasibility and oncological outcomes of laparoscopic treatment for local relapse of renal cell carcinoma

scientific article published on 3 April 2013

Feasibility of nephron-sparing surgery in giant oncocytoma

scientific article published on January 2014

Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy

scientific article published on 11 July 2014

Genomic heterogeneity of translocation renal cell carcinoma

scientific article published on July 2013

Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma

scientific article published on 21 February 2015

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

scientific article published on 2 November 2017

Gynecologic bleeding revealing vaginal metastasis of renal cell carcinoma ⬇️

scientific article published on February 14, 2013

HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysis

scientific article

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study

scientific article

High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting

scientific article published on 13 August 2015

How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma

scientific article published on 3 January 2017

How to interpret phase II data for everolimus plus bevacizumab in renal cell carcinoma

scientific article published on 5 April 2010

Hypertension and Angiotensin System Inhibitors in Patients with Metastatic Renal Cell Carcinoma

scientific article

Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape ⬇️

scientific article published on February 23, 2012

ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease

scientific article published on 24 June 2011

ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy

scientific article published on 8 October 2014

Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma

scientific article published on 01 September 2018

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

scientific article published on 11 May 2016

Immunotherapy for Renal Cancer: Sequencing and Combinations

scientific article published on December 2016

Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels

scientific article published on March 2002

Importance of Fibroblast Growth Factor Receptor in Neovascularization and Tumor Escape from Antiangiogenic Therapy ⬇️

scientific article published on February 28, 2012

Improvement in overall survival of patients with advanced renal cell carcinoma: prognostic factor trend analysis from an international data set of clinical trials

scientific article

Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy

scientific article published on 10 September 2016

Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysis

scientific article

Interest of color Doppler ultrasonography to evaluate a new anti-angiogenic treatment with thalidomide in metastatic renal cell carcinoma

scientific article published in July 2004

Interleukin-2 and interferon in metastatic kidney cancer. Experience of the French Immunotherapy Group

scientific article published in April 2002

Interleukin-6 as an emerging regulator of renal cell cancer

scientific article published on 18 August 2015

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

scientific article published in June 2004

Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.

scientific article published on 13 July 2009

Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center

scientific article

Kidney tumors

scientific article published in November 2007

Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical Trials.

scientific article published on 20 June 2017

Long-Term Safety With Axitinib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

scientific article published on 20 July 2015

Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma

scientific article published on 24 July 2015

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

scientific article published on 26 March 2018

Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET.

scientific article published on 23 July 2010

MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array

scientific article published on 21 March 2014

Malignant effusions and immunogenic tumour-derived exosomes

scientific article published in July 2002

Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab.

scientific article published on 4 November 2015

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial

scientific article

Metabolism of Kidney Cancer: From the Lab to Clinical Practice ⬇️

scientific article published on September 28, 2012

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study ⬇️

scientific article published on 23 May 2017

Metastatic kidney cancer: new therapeutic approaches

scientific article published in September 2002

Metastatic renal cell carcinoma management

scientific article published on May 2009

Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma

scientific article

Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies

scientific article published on April 2012

Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives

scientific article published on December 2012

Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes

scientific article published on 28 September 2013

New Insights into Adjuvant Renal Cell Carcinoma Treatment with Vascular Endothelial Growth Factor Inhibitors: What Have We Learned So Far?

scientific article

New therapies after failure of angiogenesis inhibitors

scientific article published on August 2009

Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes

scientific article

Nivolumab in renal cell carcinoma: latest evidence and clinical potential

scientific article published on 11 December 2016

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

scientific article published on 21 March 2018

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

scientific article published on 25 September 2015

Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?

scientific article

Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma

scientific article published on March 2010

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma

scientific article published on 12 March 2011

Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis

scientific article published on 24 September 2016

Optimal management of metastatic renal cell carcinoma: current status

scientific article published on April 2013

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials

scientific article published on 27 April 2016

Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon‐α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial ⬇️

scientific article published on October 13, 2010

Peripheral gammadelta T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma

scientific article

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

scientific article published in November 2005

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

scientific article published on September 2010

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

scientific article published on 15 August 2017

Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma

scientific article published on 21 January 2013

Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma

scientific article published on March 2007

Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer

scientific article published in April 2014

Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma

scientific article published on 3 August 2009

Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer

scientific article

Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival

scientific article

Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.

scientific article published on February 2005

Population pharmacokinetic/pharmacodynamic modeling to assist dosing schedule selection for dovitinib

scientific article

Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours

scientific article

Prediction of Progression-Free Survival Rates After Bevacizumab Plus Interferon Versus Interferon Alone in Patients with Metastatic Renal Cell Carcinoma: Comparison of a Nomogram to the Motzer Criteria ⬇️

scientific article published on December 21, 2010

Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasets

scientific article

Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancer

scientific article

Prognosis of renal-cell carcinoma: recognising host genetics ⬇️

scientific article published on December 7, 2012

Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group

scientific article

Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional study

scientific article published on 27 March 2014

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma

scientific article published on 08 October 2013

Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?

scientific article

Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study

scientific article

Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor

scientific article published in July 2008

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

scientific article published on 01 December 2018

Radiotherapy for renal-cell carcinoma

scientific article published on April 2014

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma ⬇️

scientific article

Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma

scientific article published on 26 January 2009

Randomized phase III trial of temsirolimus and bevacizumab versus interferon alfa and bevacizumab in metastatic renal cell carcinoma: INTORACT trial.

scientific article

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study

scientific article

Real world prospective experience of axitinib in metastatic renal cell carcinoma in a large comprehensive cancer centre

scientific article published on 13 May 2017

Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with everolimus

scientific article published in August 2009

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status

scientific article published on 17 December 2015

Renal cell carcinoma

scientific article published in The Lancet

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population

scientific article published on 2 March 2011

Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's Letter to the Editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and

scientific article published on 7 November 2017

Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms

scientific article published on 14 October 2013

Reversible posterior leukoencephalopathy syndrome induced by axitinib.

scientific article

Risk of a Second Kidney Carcinoma Following Childhood Cancer: Role of Chemotherapy and Radiation Dose to Kidneys

scientific article

Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life report

scientific article published on June 2016

Safety of available treatment options for renal cell carcinoma

scientific article published on 4 May 2016

Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients.

scientific article published on 13 March 2013

Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy?

scientific article published on 30 October 2011

Sequencing therapy in metastatic renal cell cancer

scientific article published on August 2013

Sequential therapy in renal cell carcinoma

scientific article published on May 2009

Sequential use of targeted agents in the treatment of renal cell carcinoma

scientific article published on 11 August 2010

Signaling inhibitors in metastatic renal cell carcinoma

scientific article published on September 2008

Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

scientific article

Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial

scientific article published on 07 October 2008

Sorafenib for the management of advanced renal cell carcinoma ⬇️

scientific article published on June 1, 2011

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

scientific article

Sorafenib-Sunitinib Sequence: The Jury Is Out.

scientific article published on 13 July 2015

Stability of preclinical models of aggressive renal cell carcinomas

scientific article

Subungual splinter hemorrhages: a clinical window to inhibition of vascular endothelial growth factor receptors?

scientific article published in August 2005

Summary of the first annual Genitourinary Medical Oncology Conference Renal Cell Carcinoma Forum

scientific article published on June 2007

Sunitinib for the management of advanced renal cell carcinoma

scientific article published on March 2010

Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.

scientific article published on 24 June 2009

Sunitinib rechallenge in metastatic renal cell carcinoma patients

scientific article published on 2 November 2010

Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma

scientific article published on 2 November 2016

Survival Prediction in Everolimus-treated Patients with Metastatic Renal Cell Carcinoma Incorporating Tumor Burden Response in the RECORD-1 Trial ⬇️

scientific article published on November 21, 2012

Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis

scientific article published on 02 June 2014

Targeted therapies for renal cell carcinoma: review of adverse event management strategies

scientific article published on 10 January 2012

Targeted therapies in the management of renal cell carcinoma: role of bevacizumab

scientific article

Targeting mTOR in cancer: renal cell is just a beginning

scientific article published on 20 June 2010

The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing

scientific article published on 25 February 2015

The interval from the last cycle of docetaxel-based chemotherapy to progression is associated with the efficacy of subsequent docetaxel in patients with prostate cancer

scientific article published on 17 May 2010

The medical treatment of metastatic renal cell cancer in the elderly: position paper of a SIOG Taskforce

scientific article published on 05 September 2008

Tivozanib for the treatment of renal cell carcinoma: results and implications of the TIVO-1 trial

scientific article

Transcription factor E3 and transcription factor EB renal cell carcinomas: clinical features, biological behavior and prognostic factors

scientific article published on 12 November 2010

Trastuzumab versus lapatinib: the cardiac side of the story

scientific article published on 28 July 2009

Treatment selection in metastatic renal cell carcinoma: expert consensus

scientific article published on 10 April 2012

Tumor growth rate provides useful information to evaluate sorafenib and everolimus treatment in metastatic renal cell carcinoma patients: an integrated analysis of the TARGET and RECORD phase 3 trial data

scientific article

Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells

scientific article

Urological cancer: towards rational post-nephrectomy follow-up guidelines in RCC.

scientific article published on 10 February 2015

Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial

scientific article

Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib

article

Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma

scientific article published on August 2011

Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma

scientific article published on June 2011

[Axitinib in metastatic renal carcinomas: update of knowledge about side effects].

scientific article published in October 2014

[Medical therapies for locally advanced/metastatic kidney cancer].

scientific article published on 18 December 2014

Paulina is supported by:

About Paulina

Help